idocaine injections in the m. Vastus intermedius and m. Rectus femoris
- Conditions
- Stroke
- Registration Number
- NL-OMON20633
- Lead Sponsor
- Roessingh Research and Development (Enschede)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 18
Age > 18 - Stroke occurred over 6 months ago - patient presents stiff knee gait - patient able to walk independently (Functional Ambulation Categories score (FAC) =3) - over activity of the m. vastus intermedius and m. rectus femoris - Patient is orientated in time, place and person and is able to understand and follow instructions
Existing pathologies or problems that are not caused by a CVA, that are of influence on the gait pattern - Allergy to lidocaine or other elements found in lidocaine hydrochloride - inflammation in the injection area
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knee flexion during gait
- Secondary Outcome Measures
Name Time Method Kinetics and kinematics of the ankle, knee, hip and pelvis and BORG and VAS questionnaires on knee stability.